Eun Sung Lee

Eun Sung Lee

Auto-generated profile, based on publicly available information

Eun Sung Lee

Asan Image Metrics, Clinical Trial Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2022 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
NKNari Kim
Nari Kim
ELEun Sung Lee
Eun Sung Lee
SWSang Eun Won
Sang Eun Won
MYMihyun Yang
Mihyun Yang
ALAmy Junghyun Lee
Amy Junghyun Lee
KKKyung Won Kim
Kyung Won Kim
Kim N, et al. Korean J Radiol. 2022 Nov;23(11):1089-1101. https://doi.org/10.3348/kjr.2022.0225

1 January 2025 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
JJJi-Sung Jang
Ji-Sung Jang
Hyo Jung ParkHyo Jung Park
Hyo Jung Park
Chong Hyun SuhChong Hyun Suh
Chong Hyun Suh
SWSang Eun Won
Sang Eun Won
ELEun Seong Lee
Eun Seong Lee
KKKyung Won Kim
Kyung Won Kim
Jang JS, et al. Korean J Radiol. 2025 Jan;26:e8. https://doi.org/10.3348/kjr.2024.0195

1 January 2025 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
SWSang Eun Won
Sang Eun Won
ELEun Sung Lee
Eun Sung Lee
Chong Hyun SuhChong Hyun Suh
Chong Hyun Suh
SKSinae Kim
Sinae Kim
Hyo Jung ParkHyo Jung Park
Hyo Jung Park
JGJeffrey P. Guenette
Jeffrey P. Guenette
Won SE, et al. Korean J Radiol. 2025 May;26(5):471-484. https://doi.org/10.3348/kjr.2024.1126

1 June 2024 in Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
PDF file
MKMi Young Kim
Mi Young Kim
SHSubin Heo
Subin Heo
SCSejin Choi
Sejin Choi
Chong Hyun SuhChong Hyun Suh
Chong Hyun Suh
ELEun Seoung Lee
Eun Seoung Lee
KKKyung Won Kim
Kyung Won Kim
Background: Intratumoral lipiodol deposition following transarterial chemoembolization (TACE) is associated with the prognosis of hepatocellular carcinoma (HCC) patients. However, there is insufficient evidence regarding the actual clinical significance of the imaging tests conducted to evaluate the lipiodol uptake after TACE. This study evaluates the clinical impact and potential utility of performing immediate post-TACE non-enhanced computed tomography (NECT) on the treatment of HCC. Methods: This retrospective study at a tertiary referral center included patients undergoing their first session of conventional TACE for initial treatment of HCC from November 2021 to December 2022 with available immediate post-TACE NECT. Patients were categorized based on lipiodol uptake into Cohorts A (incomplete uptake with additional treatment before the first follow-up 1 month after TACE), B incomplete uptake without additional treatment before first follow-up), and C (complete uptake). Survival curves for the time to progression (TTP) were estimated using the Kaplan-Meier method and were compared by using the log-rank test. Results: Out of 189 patients, 58 (29.6%) showed incomplete lipiodol uptake; 2 in Cohort A and 56 in Cohort B. Cohort C included 131 patients (69.3%). Cohort B had the highest rate of residual viable tumor (48.2%) 1 month after TACE, compared to the other cohorts (0% in Cohort A and 32.1% in Cohort C). The median TTP of Cohort B was 7.9 months [95% confidence interval (CI): 4.6–15.7 months], significantly shorter than the 15.4 months (95% CI: 10.9–20.9 months) for Cohort C (P=0.03). During follow-up, no progression occurred in Cohort A. Conclusions: Assessment of lipiodol uptake by performing immediate post-TACE NECT can stratify HCC patients and facilitate early prediction of therapeutic response. Identifying suboptimal lipiodol uptake immediately after TACE can aid future treatment adjustments and potentially improving oncologic outcomes.